A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
Clinical trial NCT07598708 · RECRUITING
Trial details
- NCT number
- NCT07598708
- Sponsor
- Centessa Pharmaceuticals (UK) Limited
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-29
- Primary completion
- 2027-09-30
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.